Gilead Sciences Inc (GILD) — Cash Flow Reinvestment Rate
Gilead Sciences Inc (GILD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.33 Billion. Check earnings quality score of Gilead Sciences Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gilead Sciences Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Gilead Sciences Inc across 24 annual periods. Explore GILD strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Gilead Sciences Inc (2002–2025)
Year-by-year capital reinvestment analysis for Gilead Sciences Inc. For live market cap and broader valuation context, see how much is Gilead Sciences Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $10.02 Billion | $0.00 | ▼ -100.0% |
| 2024 | 0.37x | $3.97 Billion | $10.83 Billion | $523.00 Million | ▲ +17.6% |
| 2023 | 0.31x | $2.50 Billion | $8.01 Billion | $585.00 Million | ▼ -11.4% |
| 2022 | 0.35x | $3.19 Billion | $9.07 Billion | $728.00 Million | ▲ +8.0% |
| 2021 | 0.33x | $3.71 Billion | $11.38 Billion | $579.00 Million | ▼ -78.9% |
| 2020 | 1.54x | $12.60 Billion | $8.17 Billion | $650.00 Million | ▲ +350.3% |
| 2019 | 0.34x | $3.13 Billion | $9.14 Billion | $825.00 Million | ▼ -82.2% |
| 2018 | 1.93x | $16.20 Billion | $8.40 Billion | $924.00 Million | ▲ +306.7% |
| 2017 | 0.47x | $5.64 Billion | $11.90 Billion | $590.00 Million | ▼ -32.5% |
| 2016 | 0.70x | $11.98 Billion | $17.05 Billion | $748.00 Million | ▲ +19.8% |
| 2015 | 0.59x | $12.47 Billion | $21.25 Billion | $747.00 Million | ▲ +312.8% |
| 2014 | 0.14x | $1.82 Billion | $12.82 Billion | $557.00 Million | ▼ -12.6% |
| 2013 | 0.16x | $505.07 Million | $3.10 Billion | $190.00 Million | ▼ -52.5% |
| 2012 | 0.34x | $1.09 Billion | $3.19 Billion | $397.00 Million | ▼ -71.9% |
| 2011 | 1.22x | $4.44 Billion | $3.64 Billion | $131.90 Million | ▲ +87.3% |
| 2010 | 0.65x | $1.85 Billion | $2.83 Billion | $61.88 Million | ▲ +107.3% |
| 2009 | 0.31x | $968.08 Million | $3.08 Billion | $230.06 Million | ▲ +485.8% |
| 2008 | 0.05x | $115.00 Million | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $78.65 Million | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $105.21 Million | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $47.95 Million | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $51.37 Million | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $38.61 Million | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $17.60 Million | $74.41 Million | $17.60 Million | — |